Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 58, No. 3-4, 2008
Issue release date: March 2009
Section title: Original Paper
Free Access
Neuropsychobiology 2008;58:178–186

Pharmacological Modulation of Dopaminergic Brain Activity and Its Reflection in Spectral Frequencies of the Rat Electropharmacogram

Dimpfel W.
Justus Liebig University Giessen, Giessen, Germany
email Corresponding Author

Wilfried Dimpfel

Justus Liebig University Giessen

c/o NeuroCode AG, Sportparkstrasse 9

DE–35578 Wetzlar (Germany)

Tel. +49 6441 200 2033, Fax +49 6441 200 2039, E-Mail w.dimpfel@neurocode-ag.com


  1. DeBoer P, Abercrombie ED: Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 receptor subtypes. J Pharmacol Exp Ther 1996;277:775–783
  2. Hamidovic A, Kang UJ, de Wit H: Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers. J Clin Psychopharmacol 2008;28:45–51.
  3. Dimpfel W, Spüler M, Koch R, SchattonW: Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats. Neuropsychobiology 1987;18:212–218.
  4. Kropf W, Kuschinsky K, Krieglstein J: Apomorphine-induced alterations in cortical EEG activity of rats: involvement of D-1 and D-2 dopamine receptors. Naunyn-Schmiedebergs Arch Pharmacol 1989;340:718–725.
  5. Stahl D, Ferger B, Kuschinsky K: Sensitization to d-amphetamine after its repeated administration: evidence in EEG and behaviour. Naunyn-Schmiedebergs Arch Pharmacol 1997;356:335–340.
  6. Vyazovskiy VV, Tobler I: Theta activity in the waking EEG is a marker of sleep propensity in the rat. Brain Res 2005;1050:64–71.
  7. Vyazovskiy VV, Achermann P, Tobler I: Sleep homeostasis in the rat in the light and dark period. Brain Res Bull 2007;74:37–44.
  8. Paxinos G, Watson C: The Rat Brain in Stereotactic Coordinates, New York, Academic Press, 1982.
  9. Gottesmann C, Kirkham PA, LaCoste G, Rodrigues L, Amaud C: Automatic analysis of the sleep-waking cycle in the rat recorded by minature telemetry. Brain Res 1977;132:562–568.
  10. Dimpfel W, Spüler M, Nickel B: Radioelectroencephalography (Tele-Stereo-EEG) in the rat as pharmacological model to differentiate the central action of flupirtine from that of opiates, diazepam and phenobarbital. Neuropsychobiology 1986;16:163–168.
  11. Entholzner E, Schneck HJ, Hargasser S, Hipp R, Tempel G: Electroencephalographic demonstration of central nervous system effects of different premedication regimes. Anaesthesist 1994;43:431–440.
  12. Röhl JE, Harms L, Pommer W: Quantitative EEG findings in patients with chronic renal failure. Eur J Med Res 2007;12:173–178.
    External Resources
  13. Ahrens H, Läuter J: Mehrdimensionale Varianzanalyse. Berlin, Academieverlag, 1974.
  14. Dimpfel W, Schober F: Norepinephrine, EEG theta waves and sedation. Brain Pharmacol 2001;1:89–97.
  15. Dimpfel W: Preclinical data base of pharmaco-specific rat EEG fingerprints (Tele-Stereo-EEG). Eur J Med Res 2003;8:199–207.
  16. Kropf W, Kuschinsky K: Effects of stimulation of dopamine D1 receptors on the cortical EEG in rats: different influences by a blockade of D2 receptors and by an activation of putative autoreceptors. Neuropharmacology 1993;32:493–500.
  17. Kropf W, Krieglstein J, Kuschinsky K: Effects of stimulation of putative dopamine autoreceptors on electroencephalographic power spectrum in comparison with effects produced by blockade of postsynaptic dopamine receptors in rats. Eur Neuropsychopharmacol 1992;2:467–474.
  18. Kropf W, Kuschinsky K: Electroencephalographic correlates of the sedative effects of dopamine agonists presumably acting on autoreceptors. Neuropharmacology 1991;30:953–960.
  19. Arnsten AF, Cai JX, Steere JC, Goldman-Rakic PS: Dopamine D2 receptor mechanisms contribute to age-related cognitive decline: the effects of quinpirole on memory and motor performance in monkey. J Neurosci 1995;15:3429–3439.
  20. Sebban C, Zhang XQ, Tesolin-Decros B, Millan MJ, Spedding M: Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission. Br J Pharmacol 1999;128:1045–1054.
  21. Beaulieu J-M, Gainetdinov RR, Caron MG: The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends in Pharmacol Sci 2007;28:166–172.
  22. Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG: An Akt/beta-arrestin 2/PP2A signalling complex mediates dopaminergic neurotransmission and behavior. Cell 2005;122:262–273.
    External Resources
  23. Alcantara AA, Chen V, Herring BE, Mendenhall JM, Berlanga ML: Localization of dopamine D2 receptors on cholinergic interneurons of the dorsal striatum and nucleus accumbens of the rat. Brain Res 2003;986:22–29.
  24. Dimpfel W: Pharmacological modulation of cholinergic brain activity and its reflection in special EEG frequency ranges from various brain areas in the freely moving rat (Tele-Stereo-EEG). Eur Neuropsychopharmacol 2005;15:673–682.
  25. Gorell JM, Czarnecki B: Pharmacologic evidence for direct dopaminergic regulation of striatal acetylcholine release. Life Sci 1986;38:2239–2246.
  26. Zhang L, Liu Y, Chen X: Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L-type channels in the rat. J Physiol 2005;568:469–481.
  27. Pisani A, Bonsi P, Centonze D, Calabresi P, Bernardi G: Activation of D2-like dopamine receptors reduces synaptic inputs to striatal cholinergic interneurons. J Neurosci 2000;20:1–6.
    External Resources
  28. Van Koppen CJ, Kaiser B: Regulation of muscarinic acetylcholine receptor signaling. Pharmacol Ther 2003;98:197–220.
  29. Fujishiro H, Umegaki H, Suzuki Y, Oohara-Kurotani S, Yamaguchi Y, Iguchi A: Dopamine D2 receptor plays a role in memory function: implications of dopamine-acetylcholine interaction in the ventral hippocampus. Psychopharmacology (Berl) 2005;182:253–261.
  30. Hefco V, Yamada K, Hefco A, Hritcu L, Tiron A, Olariu A, Nabeshima T: Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats. Eur J Pharmacol 2003:474:227–232.
  31. Marshall DL, Redfern PH, Wonnacott S: Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine treated rats. J Neurochem 1997;68:1511–1519.
  32. Ferger B, Kropf W, Kuschinsky K: Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine or d-amphetamine activate D1 rather than D2 receptors. Psychopharmacology 1994;114:297–308.
  33. Homan CN, Wenzel K, Suppan K, Ivanic G, Kriechbaum N, Crevenna R, Ott E: Sleep attacks in patients taking dopamine agonists: review. BMJ 2002;324:1483–1487.
  34. Dimpfel W, Hoffmann JA: Electropharmacograms of rasagiline, aminoindane and selegiline in the freely moving rat. Parkinsonism Relat Disord 2007;13(suppl 2):102, P2.218.